Abstract

BackgroundMortality in end stage renal disease (ESRD) is higher than many malignancies. There is no data about the optimal way to present information about projected survival to patients with ESRD. In other areas, graphs have been shown to be more easily understood than narrative. We examined patient comprehension and perspectives on graphs in communicating projected survival in chronic kidney disease (CKD).MethodsOne hundred seventy-seven patients with CKD were shown 4 different graphs presenting post transplantation survival data. Patients were asked to interpret a Kaplan Meier curve, pie chart, histogram and pictograph and answer a multi-choice question to determine understanding.ResultsWe measured interpretation, usefulness and preference for the graphs. Most patients correctly interpreted the graphs. There was asignificant difference in the percentage of correct answers when comparing different graph types (p = 0.0439). The pictograph was correctly interpreted by 81% of participants, the histogram by 79%, pie chart by 77% and Kaplan Meier by 69%. Correct interpretation of the histogram was associated with educational level (p = 0.008) and inversely associated with age > 65 (p = 0.008). Of those who interpreted all four graphs correctly, there was an association with employment (p = 0.001) and New Zealand European ethnicity (p = 0.002).87% of patients found the graphs useful. The pie chart was the most preferred graph (p 0.002).The readability of the graphs may have been improved with an alternative colour choice, especially in the setting of visual impairment.ConclusionVisual aids, can be beneficial adjuncts to discussing survival in CKD.

Highlights

  • Mortality in end stage renal disease (ESRD) is higher than many malignancies

  • Prevalent dialysis patients aged 65–69 in the US have an expected 4.65 year life expectancy [3].For suitable patients, transplantation has been shown to result in a significant survival benefit [4]

  • There is no data about the optimal way to present information about projected survival to patients with ESRD

Read more

Summary

Introduction

Mortality in end stage renal disease (ESRD) is higher than many malignancies. There is no data about the optimal way to present information about projected survival to patients with ESRD. We examined patient comprehension and perspectives on graphs in communicating projected survival in chronic kidney disease (CKD). Mortality in end stage renal disease (ESRD) can be higher than in many malignancies [1]. For those commencing treatment aged 45–64 is 6.6 years in Australia and 5.5 years in New Zealand. In the 65–74 age group, median survival is 4.3 years in Australia and 3.7 years in New Zealand [2]. Prevalent dialysis patients aged 65–69 in the US have an expected 4.65 year life expectancy [3].For suitable patients, transplantation has been shown to result in a significant survival benefit [4].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call